Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OMHE_is_a_WEED_Company_THC_&_CBD_both_are_Extracted_from_MJ
OMHE CEO Letter - MMJ/CBD Plans
OMHE_is_a_MMJ_Company: Keystone Shops opening medical marijuana dispensaries in King of Prussia, South Philly
READ HERE
Australian_Researchers Announce Study_to_Determine if Cannabis Can Treat_Patients with Tourette Syndrome
OMHE IS ALREADY WORKING ON MMJ/CBD BASED PAIN TREATMENT THERAPUTICS
READ HERE
Judge orders Illinois to expand medical marijuana qualifying conditions to include pain
READ HERE
OMHE is already working on CBD based pain treatment. BIG NEWS IS EXPECTED ANY TIME!
Cannabidiol (CBD) is just one of over 85 cannabinoids presently identified in the cannabis plant and is the second most abundant cannabinoid in marijuana after THC. CBD can be extracted from Marijuana or Hemp. So you can't say CBD is not weed (mj).
OMHE is a WEED (MMJ) Stock!
PROOF: OMHE CEO LETTER - READ HERE
West Virginia Legislature may improve medical cannabis law in 2018
READ HERE
America’s largest veteran group is calling for medical cannabis research
OMHE is ALREADY DOING MMJ R&D...WORKING ON FDA APPROVAL
READ HERE
California special needs students would be allowed to use medical marijuana in school under new legislation
READ HERE
Minnesota medical_marijuana patients report significant pain reduction
READ HERE
Illinois Senate Approves Marijuana Legalization Ballot Question
READ HERE
18Q2 Fin Was Released on 2/9/2018
See 18Q2 Results Here
ENRT_Heavy_Selling_is_Coming_PPS_will_be_SubPenny_SOON
ENRT_is_a_sleeping_giant???Listen_It_Will_Never_Wakup.
ENRT SELL OFF IS COMING
PPS WILL BE 0.001
ENRT is a junk stock.
ENRT Will Soon Go Back To 0.01
Its a SCAM!
Heavy Selling is coming.
Good News Not Expected Until 2073
ENRT Heavy Selling is coming. Stock PPS will go down rapidly!
You got it, Peter. Everyone posting on this board, no matter what, knows the huge potential of OMHE; otherwise, we won't find them here!!
OMHE is heading to $1
ThxToJS: Congress Will Make Marijuana Legal
https://www.politico.com/magazine/story/2018/01/06/jeff-sessions-marijuana-legalization-congress-216251
Agreed_Med_Dev_&_Prescrip_Drugs_R_Tow_Different_Things_Inviting_U_to_Re_read_OMHE_PR
12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here
OMHE_Medical_Device_is_of_Low_Risk_Will_Cost_Less_Than_$31Million_For_FDA_Approval
because of late-phase development approach.
https://medcitynews.com/2010/11/medical-device-makers-spend-millions-to-meet-fda-rules-study-finds/
12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here
There will never be a long silence again. There was a reason of long silence.
Sessions_Actions_Will_Not_Affect_OMHE_as_OMHE_is_Working_on_MMJ_R&D_FDA_Approval
Medical Marijuana's (MMJ) future is BRIGHT!
Also, even his party is not with him on his Recreational Marijuana (RMJ) plans:
https://www.yahoo.com/news/republican-sen-gardner-torches-sessions-pot-crackdown-162956937.html
I think, soon he will be shown the door!!
I am here my friend. OMHE_is_heading_to_$1
Didn't_Post_a_Message_hoping_PPS_will_go_down_so_I_will_load_more_BUT_that_didnt_happen
OMHE PPS is so resilient that even without a news/fins, it is not going down.
Time to buy at low price is over because of HUGE in motion projects and big revenue add deals.
TOO BAD AND TOO GOOD
Have a Happy Holidays folks....no matter if its a holiday season or no fins.....OMHE PPS WILL REMAIN STRONG!!!!
OMHE_NEXT_FY_REVENUE_WILL_BE_EVEN_MORE_THAN_$20Million
DEC-2017-PR-READ-HERE_OMHE_PROVIDED_A_SUCCESS_PLAN
Omni Health’s Consumer Goods Division will be operating via a subsidiary, Celebrity Brands Inc. Celebrity Brands will bring an entirely new reach to Omni Health’s operations with a new set of investment priorities and a sharpened set of portfolio choices to accelerate growth and performance. The company will also focus on strengthening its portfolio by acquiring a number of consumer, revenue-generating brands, and by creating a platform for future acquisitions that scale the distribution of company’s existing brands.
OMHE Stock Price is HEADING TO ONE DOLLAR
OMHE_Has_Shown_Success_Next_FY_Rev~$20Million_From_Current_$4.6Million_ie_4x
OMHE also developed Marijuana Medicine and applying for FDA Approval
(1) Current Annual Revenue................................................................................=$4.6 Million
(2) New Revenue from OverTheCounter CBD Analgesic Creams/Ointments.…=$7.0 Million+
(3) New Revenue from Consumer Goods Division..............................................=$7.0 Million+
PROOF (1) <<< CLICK Here to Read Details
FDA_will_Approve_OMHE’s_CBD_based_Pain_Medicine_in_2018
OMHE gave conservative timeframe of three years as any public company would do but in reality this will happen sooner due to the following reasons:
(1) OMHE is reformulating its most successful (almost 4 decades old) proprietary formularies to include cannabidiol (CBD); so therapeutic is not new and has a proven record.
(2) OMHE is using FDA regulations-savvy, ‘fast-track’ pipeline strategy & will be in a position to partner for late-phase development. Minimum approval timeframe for phase-3 is 1 year.
(3) OMHE & others understand that due to current dreadful opioids epidemic, cannabidiol drug is the best alternative, therefore processing will be faster.
(4) OMHE said on Dec 5, 2017 that "plan already in motion".
12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here
So IMO, approval will be granted in 2018.
OMHE PPS is heading to $1
OMHE 2ndQ2018 Result - Expected Anytime!!
Get Ready for another Stellar Update!
*NOV2017_OMHE_Announced_CBD_goods_JointVenture_Plan*DEC2017_FollowedUp_With_Details
NOV2017_OMHE_Announced_CBD_goods_JointVenture_Plan - READ FULL PR HERE
OMHE to get High-Profile Celebrity Endorsements
Omni Health Announced Launch of Consumer Goods Division - READ HERE
OMHE_will_get_Medical_Marijuana_Cultivation_License_in_2018
In Feb 2017 OMHE shared its vision and indicated its plan on working on therapeutic cannabis products and licensed medical marijuana cultivation.
CLICK HERE TO READ FEB 2017 OMHE VISION & FUTURE PLANS
OMHE_is_Adding_$7Million_in_Rev_By_Supplying_OverTheCounter_MJ_Ointments_to_Doctors, Clinics & Hospitals
12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here
OMHE_Projected_Annual_Revenue_Close_to_$20Million
OMHE also developed Marijuana Medicine and applying for FDA Approval
(1) Current Annual Revenue................................................................................=$4.6 Million
(2) New Revenue from OverTheCounter CBD Analgesic Creams/Ointments.…=$7.0 Million+
(3) New Revenue from Consumer Goods Division..............................................=$7.0 Million+
PROOF (1) <<< CLICK Here to Read Details
OMHE@4c_Rev~$20Mil_FDAcbdMed_ShareRestruc_QBuplist_MMJcultivation_OvrTCntrCBD_NEXT
HERE is WHAT OMHE HAS ACCOMPLISHED SO FAR
(1) In Feb 2017 OMHE shared its vision and indicated its plan on working on therapeutic cannabis products and licensed medical marijuana cultivation.
CLICK HERE TO READ FEB 2017 OMHE VISION & FUTURE PLANS
(2) In My 2017 OMHE announced the opening of its Biotech R&D Lab.
CLICK HERE TO READ MAY 2017 LAB ANNOUNCEMENT
(3) In June 2017 Biotech scientists with FDA/regulatory approval joined OMHE.
CLICK HERE TO READ JUNE 2017 SCIENTISTS ANNOUNCEMENT
(4) In Nov 2017 OMHE updated about cannabinoid-based drug-development.
CLICK HERE TO READ NOV 2017 DRUG DEVELOPMENT UPDTE
(5) In Dec 2017 OMHE announced its plan already in motion to create a drug candidate compelling to Big Pharma, development of cannabidiol pain treatment therapeutic & medicine and filing of FDA registration by employing an FDA regulations-savvy, ‘fast-track’ pipeline strategy.
CLICK HERE TO READ DEC 2017 FDA REGISTRATION UPDATE
(6) In Dec 2017 OMHE announced launch of $7 million revenue generating Consumer Goods Division operating under subsidiary, Celebrity Brands Inc; plan of acquiring a number of consumer, revenue-generating brands, and by creating a platform for future acquisitions that scale the distribution of company’s existing brands; and first wholesale order is from Amerimark Direct for Celeb Cream – one of the Company’s innovative anti-aging products.
CLICK HERE TO READ DEC 2017 Consumer Goods Division ANNOUNCEMENT
(7) In Dec 2017 OMHE announced 3.7 Million Euro distribution agreement across Europe.
CLICK HERE TO READ DEC 2017 3.7 MILLION EURO DISTRIBUTION AGREEMENT